Bank of New York Mellon »

Verve Therapeutics shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Verve Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Verve Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verve Therapeutics by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.8M 200k 13.94
2023-09-30 $2.5M 187k 13.26
2023-06-30 $3.5M 187k 18.75
2023-03-31 $2.5M 171k 14.42
2022-12-31 $3.4M 174k 19.35
2022-09-30 $11M 170k 66.67
2022-06-30 $1.6M 104k 15.30
2022-03-31 $2.6M 116k 22.82
2021-12-31 $2.9M 79k 36.88
2021-09-30 $2.6M 56k 47.01